CRISPR, Biotechnology
Intellia Pauses Late-Stage CRISPR Trials After Severe Liver Injury Hospitalization
100% left coverage1 source
CRISPR
First 100 Days
See how you scored in predicting Trump's first 100 days
Latest News
CRISPR, Biotechnology
Intellia Pauses Late-Stage CRISPR Trials After Severe Liver Injury Hospitalization
100% left coverage1 source
CRISPR, Biotechnology
CRISPR Therapeutics Unveils SyNTase Gene Editing Data Showing Breakthrough 95% Success at ESGCT 2025
100% left coverage1 source
CRISPR, Biotechnology
CRISPR Therapeutics Unveils SyNTase Gene Editing Data Showing Breakthrough 95% Success at ESGCT 2025
100% left coverage1 source
CRISPR, Biotechnology
CRISPR Therapeutics, Sirius Initiate Phase 2 European Trial of FXI Inhibitor SRSD107 for VTE Prevention
100% left coverage1 source
CRISPR, Biotechnology
CRISPR Therapeutics, Sirius Initiate Phase 2 European Trial of FXI Inhibitor SRSD107 for VTE Prevention
100% left coverage1 source
CRISPR, Academia
Tulane Researchers Develop CRISPR Tongue Swab Revolutionizing Tuberculosis Detection
100% left coverage1 source
CRISPR, Academia
Tulane Researchers Develop CRISPR Tongue Swab Revolutionizing Tuberculosis Detection
100% left coverage1 source
CRISPR, Biotechnology
CRISPR Therapeutics Reports $208.5M Q2 Loss, Activates 75 Global Treatment Centers
100% left coverage1 source
CRISPR, Biotechnology
CRISPR Therapeutics Reports $208.5M Q2 Loss, Activates 75 Global Treatment Centers
100% left coverage1 source
CRISPR, Biotechnology
Japanese Court Upholds UC CRISPR Patent in Global Legal Battle
100% left coverage1 source
CRISPR, Biotechnology
Japanese Court Upholds UC CRISPR Patent in Global Legal Battle
100% left coverage1 source
CRISPR, Biotechnology
CRISPR Center Launches with $20M to Develop Personalized Therapies
100% left coverage2 sources
CRISPR, Biotechnology
CRISPR Center Launches with $20M to Develop Personalized Therapies
100% left coverage2 sources
First 100 Days
See how you scored in predicting Trump's first 100 days
Most Reported By
News from CRISPR
News from CRISPR